Answers are grounded in this paper and cite their sources.
Long-term, disease-free breast cancer survivors reported high levels of functioning and QOL many years after primary treatment. However, past systemic adjuvant treatment was associated with poorer functioning on several dimensions of QOL. This information may be useful to patients and physicians who are engaging in discussion of the risks and benefits of systemic adjuvant therapy.
No takes yet. Share an insight, caveat, or question.
Peter Ganz (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: